Call: Andes Virus and Hantavirus Research
- Published
- 29 Sept 2026
- Closes
- 11 Dec 2026
- Reference
- call-andes-virus-and-andv-relevant-hantavirus-research-isidore-ii-free
- Sector
- Healthcare & Pharma
At a glance
A buyer has published a funding call in healthcare & pharma: “Call: Andes Virus and Hantavirus Research”. Submissions close on 11 December 2026, 66 days from today. Quote reference call-andes-virus-and-andv-relevant-hantavirus-research-isidore-ii-free in any correspondence with the buyer. There are 19,473 open healthcare & pharma notices on FreeTender. Bids are submitted to the buyer through fundsforNGOs — grants & funding calls, not through FreeTender.
Details
The ISIDORe II project invites applications for free-of-charge Transnational Access (TNA) to research infrastructure services supporting Andes virus (ANDV) and ANDV-relevant hantavirus research. The call supports proposals that address one or more of the project’s priority areas and request relevant services from the ISIDORe II catalogue. The application deadline is 11 December 2026 (time zone and deadline time not specified in the source). This opportunity is part of the ISIDORe II “response action” framework and is designed to provide researchers with service-based access to infrastructure capabilities. Applicants must submit proposals addressing one or more priority areas and explain why the requested ISIDORe II service(s) are needed for their work. The call text highlights that applicants should download the full call text before applying, as it contains additional detail on scope, eligibility conditions, and application requirements. This is a free-of-charge Transnational Access (TNA) opportunity. The specific amount of funding or service “value” per award is not specified in the source. Benefits consist of access to ISIDORe II research infrastructure services, selected from the catalogue. Services span multiple technical categories, including: Cost coverage details are not stated in the provided article text beyond the opportunity being free-of-charge.
The call is open to:
The source also includes these eligibility-related conditions: No further exclusions, required consortia structures, or institution types are specified in the provided text. Applicants must address one or more priority areas and must request access to one or more services available through the ISIDORe II services catalogue.
The priority areas listed are:
Service-based evaluation, comparison, or characterisation of existing therapeutic or non-vaccine prophylactic candidates against ANDV or ANDV-relevant hantaviruses. Priority is given to proposals that generate additional preclinical or translationally relevant evidence using ISIDORe II services. Service-based development, adaptation, analytical evaluation, benchmarking, or characterisation of diagnostic tools, assays, reagents, reference materials, or related research tools. Priority is given to proposals that address gaps in diagnostic/assay readiness, such as analytical sensitivity, specificity, cross-reactivity, robustness, portability, standardisation, and access to appropriate controls, panels, sera, antibodies, recombinant proteins, or viral material. Service-based use, comparison, or characterisation of models, experimental approaches, or readouts for ANDV or ANDV-relevant hantavirus research. Priority is given to proposals that determine suitability of a model/system/readout for defined purposes (e.g., pathogenesis studies, tropism studies, host-response analysis, or research on medical countermeasures). This TNA call is structured to help researchers advance ANDV and ANDV-relevant hantavirus work by enabling access to specialised research capabilities—ranging from molecular and sequencing services to imaging, in vivo and ex vivo systems, regulatory and clinical research support, and elements of vaccine development. It is particularly relevant for projects that need specific infrastructure services that can be requested via the ISIDORe II catalogue, and for teams preparing diagnostics, therapeutic evaluation, or model/readout validation. The source provides partial application instructions and indicates that a full call text is available. Follow the steps below based on the information shown: The source explicitly advises applicants to read the call criteria and eligibility conditions. If you do not have an ORCID, the source directs applicants to orcid.org to obtain one. The source indicates you should select from the catalogue, but the visible text ends before the full selection and submission workflow is shown. The source includes a form link button/text (the detailed submission steps and all required documents are not fully shown in the supplied article text). For downloading the full call text and accessing the application form, use the official ISIDORe call page here:
Deadline reminder: Applications must be submitted by 11 December 2026 (deadline time and time zone not specified in the source).
What is the ISIDORe II call offering? It offers free-of-charge Transnational Access (TNA) to research infrastructure services that support Andes virus (ANDV) and ANDV-relevant hantavirus research. Who can apply? Researchers from academia, public research organisations, public-health-linked research bodies, industry, SMEs, and other relevant research-performing organisations can apply. What is the application deadline? The deadline is 11 December 2026. The source does not specify the deadline time or time zone. Do I need an ORCID? Yes. The source instructs applicants to prepare an ORCID number. If you do not have one, it directs you to orcid.org. What do I need to include in my proposal? You should address one or more priority areas and request access to one or more services from the ISIDORe II catalogue. You must also explain the main priority area and why the requested service(s) are needed. Are international applicants eligible? International users may be supported, but the source notes a Horizon Europe TNA rule: at least 80% must benefit users from EU Member States or Horizon Europe-associated countries, while up to 20% may support international users where justified and eligible under ISIDORe II rules. Where can I find the complete application requirements? The source advises downloading the full call text, which contains detailed scope, eligibility conditions, and application requirements. Use the official call page for access. Review the official ISIDORe II call page and download the full call text to confirm detailed eligibility requirements, service selection rules, and the complete application instructions. Then prepare your ORCID and draft a proposal
Context for bidders
There are 19,473 open Healthcare & Pharma tenders. This one closes in 66 days.
Similar Healthcare & Pharma tenders
- Tender for Non Medical Equipment Repairing and AMC at Balaghat· closes 13 Oct
- Public notice regarding procurement of reagents for hematology analyzer at Dr Hedgewar Arogya Sansthan· closes 15 Oct
- Приобретение лабораторного оборудования· closes 13 Oct
- Закуп Комплекта запасных частей инструментов и принадлежностей для дефибриллятора· closes 13 Oct
- Приобретение лабораторного оборудования· closes 13 Oct
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Public notice regarding procurement of reagents for hematology analyzer at Dr Hedgewar Arogya SansthanHealth & Family Welfare Department, Govt. of NCT of Delhi · India
- Proposed Construction of Modern Laundry at Kapsabet County Referral HospitalNandi County Government · Kenya
- Поставка лекарственного препарата для медицинского применения ЦЕФТАЗИДИМ+[АВИБАКТАМ]КРАЕВОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ "АЛТАЙСКИЙ КРАЕВОЙ ОНКОЛОГИЧЕСКИЙ ДИСПАНСЕР" · Russia
- Поставка лекарственного препарата для медицинского применения бромдигидрохлорфенилбензодиазепинКРАЕВОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ "АЛТАЙСКИЙ КРАЕВОЙ НАРКОЛОГИЧЕСКИЙ ДИСПАНСЕР" · Russia
- Лекарства, реактивы, реагенты, изделия медицинского назначения: Медицинские изделия одноразового использования № 58 (шовный материал)ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ ОБРАЗОВАТЕЛЬНОЕ УЧРЕЖДЕНИЕ ВЫСШЕГО ОБРАЗОВАНИЯ "СИБИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ · Russia
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →